LSL Videos

MANUFACTURING AND SUPPLY CHAIN RISK MITIGATION STRATEGIES AMIDST COVID-19

TACKLING HR IN BIOPHARMA DURING A PANDEMIC

ACCELERATING YOUR BIOPHARMA STARTUP'S PATH TO THE CLINIC

  • Accelerating Your Biopharma Startup’s Path To The Clinic

    Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics, and Dara Lockert, founder and executive director of Spannerwerks, a consultancy, share best practices and lessons learned during the drive to get a biopharma startup to the clinic as quickly as possible. 

  • Applying A Partnering Approach To Meeting Unmet Medical Need

    In this video, Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics; and Dara Lockert, founder and executive director of Spannerwerks, discuss the why behind taking an outsourced/partnered approach to drug development, along with how to go about assessing consultancies in the process. 

  • Why Taking A Partnered Approach To The Clinic Makes Sense

    Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics, a clinical-stage oncology company; and Dara Lockert, founder and executive director of Spannerwerks, a life science industry consultancy. provide insight on differences between startups of yesteryear versus today, and what’s important when seeking the best partners.

  • Determining What Expertise Is Needed In A Partnered Drug Development Model

    Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics, a clinical-stage oncology company; and Dara Lockert, founder and executive director of Spannerwerks, a life science industry consultancy chat about strategic versus tactical expertise, and figuring out what needed internally versus what could be outsourced.

  • How To Create Interest And A Sense Of Urgency In An Outsourced Drug Development Model

    Rob Wright, chief editor of Life Science Leader, conducted an executive virtual roundtable with Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics, a clinical-stage oncology company; and Dara Lockert, founder and executive director of Spannerwerks, a life science industry consultancy. In this portion, Contag and Lockert share some of the practices used toward keeping outsourced partners excited and interested in the project, along with approaches used to create a sense of urgency. 

  • The Outsourcing Selection Process

    Rob Wright, chief editor of Life Science Leader, conducted an executive virtual roundtable with Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics, a clinical-stage oncology company; and Dara Lockert, founder and executive director of Spannerwerks, a life science industry consultancy. In this component, Contag and Lockert get into the CRO and CMO selection process, sharing an anecdote of reverse engineering from a future launch of what all needs to happen and why. 

  • What To Avoid And Pearls Of Wisdom In A Partnered Drug Development Model

    Rob Wright, chief editor of Life Science Leader, conducted an executive virtual roundtable with Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics, a clinical-stage oncology company; and Dara Lockert, founder and executive director of Spannerwerks, a life science industry consultancy. In this concluding section, Contag and Lockert provide advice for CEOs on things to avoid when outsourcing clinical trials, and parting pearls of wisdom to keep in mind when partnering for drug development.

PREPARING FOR THE NEW BIOMANUFACTURING FRONTIER: A FIRESIDE CHAT WITH FLUGEN'S ANDY SKIBO

BIOPHARMA AND THE MANAGEMENT OF WALL ST. DURING A PANDEMIC

  • Biopharma And The Management Of Wall St. During A Pandemic

    The volatility of the U.S. stock market in the first half of 2020 has even the heartiest investor queasy. But how about the leaders of such publicly traded companies? We conduct a virtual roundtable with three CEOs of publicly traded biopharmaceutical companies to learn how they are leading their organizations while also managing the expectations of Wall Street during the COVID-19 pandemic.

AN INTERVIEW WITH ROBERT HARIRI, M.D., PH.D., CEO AND FOUNDER OF CELULARITY

VIRTUAL ROUNDTABLES

During the COVID-19 pandemic of 2020, Life Science Leader decided to engage with some of our executive-level readers via Zoom conference calls. These virtual roundtables were hosted by our Chief Editor Rob Wright and then broken up into shorter clips based on specific questions or topics discussed during the full-length call.